Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Melloni

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Oncotarget|September 24, 2016
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemiaRebecca Voltan, Erika Rimondi, Elisabetta Melloni, et al.
Clinical Science (London, England : 1979)|May 18, 2019
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets?Stella Bernardi, Rebecca Voltan, Erika Rimondi, et al.
Nutrients|April 13, 2023
<i>Convolvulus pluricaulis</i> Choisy's Extraction, Chemical Characterization and Evaluation of the Potential Effects on Glycaemic Balance in a 3T3-L1 Adipocyte Cell ModelElisabetta Melloni, Silvia Grassilli, Arianna Romani, et al.
Frontiers in Immunology|August 1, 2020
Eosinophils and Purinergic Signaling in Health and DiseaseDavide Ferrari, Marta Vuerich, Fabio Casciano, et al.
Current Oncology (Toronto, Ont.)|July 21, 2021
Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological InhibitorsErika Rimondi, Elisabetta Melloni, Arianna Romani, et al.
Experimental Dermatology|August 27, 2025
Trained Immunity and Its Potential Implications in the Etiopathogenesis of Hidradenitis Suppurativa: A New Paradigm in Chronic Inflammation?Annalisa Marcuzzi, Erika Rimondi, Giada Lodi, et al.
Nanomaterials (Basel, Switzerland)|April 1, 2020
Colorectal Cancer Study with Nanostructured Sensors: Tumor Marker Screening of Patient BiopsiesMichele Astolfi, Giorgio Rispoli, Gabriele Anania, et al.
Life (Basel, Switzerland)|May 25, 2024
Characterization Methods for Nanoparticle-Skin Interactions: An OverviewValentyn Dzyhovskyi, Arianna Romani, Walter Pula, et al.
Biomolecules|July 29, 2025
Phytocompounds in Precision Dermatology: COX-2 Inhibitors as a Therapeutic Target in Atopic-Prone SkinMuhammad Suleman, Abrar Mohammad Sayaf, Chiara Moltrasio, et al.
International Journal of Nanomedicine|April 16, 2024
Microfluidic Fabricated Liposomes for Nutlin-3a Ocular Delivery as Potential Candidate for Proliferative Vitreoretinal Diseases TreatmentElisabetta Esposito, Elena Pozza, Catia Contado, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Oncotarget|September 24, 2016
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemiaRebecca Voltan, Erika Rimondi, Elisabetta Melloni, et al.
Clinical Science (London, England : 1979)|May 18, 2019
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets?Stella Bernardi, Rebecca Voltan, Erika Rimondi, et al.
Nutrients|April 13, 2023
<i>Convolvulus pluricaulis</i> Choisy's Extraction, Chemical Characterization and Evaluation of the Potential Effects on Glycaemic Balance in a 3T3-L1 Adipocyte Cell ModelElisabetta Melloni, Silvia Grassilli, Arianna Romani, et al.
Frontiers in Immunology|August 1, 2020
Eosinophils and Purinergic Signaling in Health and DiseaseDavide Ferrari, Marta Vuerich, Fabio Casciano, et al.
Current Oncology (Toronto, Ont.)|July 21, 2021
Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological InhibitorsErika Rimondi, Elisabetta Melloni, Arianna Romani, et al.
Experimental Dermatology|August 27, 2025
Trained Immunity and Its Potential Implications in the Etiopathogenesis of Hidradenitis Suppurativa: A New Paradigm in Chronic Inflammation?Annalisa Marcuzzi, Erika Rimondi, Giada Lodi, et al.
Nanomaterials (Basel, Switzerland)|April 1, 2020
Colorectal Cancer Study with Nanostructured Sensors: Tumor Marker Screening of Patient BiopsiesMichele Astolfi, Giorgio Rispoli, Gabriele Anania, et al.
Life (Basel, Switzerland)|May 25, 2024
Characterization Methods for Nanoparticle-Skin Interactions: An OverviewValentyn Dzyhovskyi, Arianna Romani, Walter Pula, et al.
Biomolecules|July 29, 2025
Phytocompounds in Precision Dermatology: COX-2 Inhibitors as a Therapeutic Target in Atopic-Prone SkinMuhammad Suleman, Abrar Mohammad Sayaf, Chiara Moltrasio, et al.
International Journal of Nanomedicine|April 16, 2024
Microfluidic Fabricated Liposomes for Nutlin-3a Ocular Delivery as Potential Candidate for Proliferative Vitreoretinal Diseases TreatmentElisabetta Esposito, Elena Pozza, Catia Contado, et al.
Pageof 7